Day: December 3, 2018

Pasinex Reports Third Quarter Results

TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (The “Company” or “Pasinex”) reported a small loss for the third quarter (Q3) of 2018 of $0.2 million compared to net income of $1.8 million in Q3 2017. The decrease in net income is due to a lower equity gain from Horzum AS (the 50% owned joint venture that holds the Pinargozu mine) caused mainly by the drop in zinc prices in Q3. Highlights – Q3 2018 and 2017 (1) (Canadian dollars) Third Quarter       2018     2017   Pasinex financial results:  

Trican Announces Pricing of Secondary Offering of Keane Shares

CALGARY, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) — Trican Well Service Ltd. (TSX: TCW) (“Trican” or the “Company”) today announced the pricing of an underwritten secondary offering of common shares (“Keane Shares”) of Keane Group Inc. (“Keane Group”) by one of its stockholders, Keane Investor Holdings, LLC (the “Selling Stockholder”), of 5,251,249 Keane Shares for proceeds, after underwriting fees and discounts of approximately US$56 million.  The offering is expected to close on December 6, subject to customary closing conditions. ABOUT TRICAN Headquartered in Calgary, Alberta, Trican provides a comprehensive array of specialized products, equipment and services that are used during the

LeddarTech Accelerates Momentum with $US 23.7 Million in Bridge Financing

Latest financing to support LeddarTech’s accelerated growth and development efforts for its proprietary solutions based on its unique automotive LiDAR development platform, which is rapidly gaining traction with Tier-1 suppliers QUEBEC CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable automotive LiDAR development platform, announces the successful closing of a $US 23.7 million ($CDN 31.4 million) bridge. These funds will enable the company to continue the expansion of its research and development teams to accelerate the introduction of its automotive LiDAR development platform. The financing consists of a revolving loan from Desjardins

THL Credit Senior Loan Fund Declares Monthly Distribution of $0.101 Per Share and Announces Investor Call

BOSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — THL Credit Senior Loan Fund (the “Fund”) (NYSE: TSLF) today announced the declaration of monthly distributions of $0.101 per common share, payable on the dates noted below.  Based on the Fund’s share price of $15.58 as of its close on December 3, 2018, the distribution represents an annualized yield of 7.78%.  Information regarding the distribution rate is included for informational purposes only and is not necessarily indicative of future results, the achievement of which cannot be assured.  The distribution rate should not be considered the yield or total return on an investment in

Friedman Industries, Incorporated Announces Cash Dividend

Longview, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NYSE—American; Trading Symbol: FRD) The Board of Directors of Friedman Industries, Incorporated, a Texas-based company engaged in pipe manufacturing, steel processing and steel and pipe distribution, declared on December 3, 2018, a cash dividend of $0.06 per share on the Common Stock of the Company. The Company will pay the cash dividend on February 8, 2019, to shareholders of record at the close of business on January 11, 2019.  For further information regarding this dividend, please contact Mr. Alex LaRue, Chief Financial Officer – Secretary and Treasurer at (903)758-3431.

Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting

P-BCMA-101 showed a 100% ORR with patients achieving rapid and deep responses with no CRS or neurotoxicity observed at the planned Phase 2 dose SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today provided an update on the ongoing Phase 1 clinical trial of its autologous P-BCMA-101, a chimeric antigen receptor T-cell (CAR-T) product candidate in relapsed/refractory multiple myeloma, during an oral presentation at the 2018 American Society of Hematology (ASH) Annual Meeting.  As of the data cutoff date, 23 patients had been

Atara Biotherapeutics Announces Next-Generation CAR T Discoveries and Positive T-Cell Immunotherapy Results in Patients with EBV+ PTLD Involving the CNS at 60th American Society of Hematology (ASH) Annual Meeting

Moffitt Cancer Center collaborators described next-generation chimeric antigen receptor T-cell (CAR T) technology that increases T cell persistence and decreases exhaustion Memorial Sloan Kettering collaborators presented positive Phase 2 clinical results for EBV-specific T cells in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder (EBV+ PTLD) involving the central nervous system (CNS) PTLD patient treatment patterns and health outcomes are described in additional ASH presentations SOUTH SAN FRANCISCO, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced results

ValOre Announces Rights Offering

VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) — ValOre Metals Corp. (TSX-V: VO) (“ValOre” or the “Company”) today announced that it will conduct an offering (the “Rights Offering”) of rights (“Rights”) to acquire common shares of the Company (“Shares”) for gross proceeds of C$2.45 million. Rights Offering Pursuant to the rights offering circular (the “Rights Offering Circular”) and the notice of rights offering (the “Notice of Rights Offering”) for the Rights Offering, each eligible registered shareholder of the Company resident in Canada holding Shares as at the close of business on December 10, 2018 (the “Record Date”) will receive

Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia  

82 percent of Patients Achieved a Complete Remission when Lymphodepletion Regimen Included an anti-CD52 Monoclonal Antibody (mAb) Safety Profile of UCART19 Appears Manageable with No Evidence of Moderate or Severe Graft-vs-Host Disease (GvHD) and No Severe Neurotoxicities Analysis Suggests that an anti-CD52 mAb May Be an Important Contributor for AlloCAR T™ Cell Expansion and Now Mandated in the UCART19 Trials SOUTH SAN FRANCISCO, Calif. and PARIS, Dec. 03, 2018 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, and Servier, an independent international pharmaceutical company,

Revasum commences trading on the ASX

Highlights: Revasum to list today at 12.00pm following a fully underwritten Initial Public Offering (IPO) which raised A$30.7 million The IPO received strong support from some of Australia’s leading Institutional Investors Revasum recently selected as strategic partner for Silicon Carbide production by major semiconductor device manufacturer – a major endorsement of Revasum’s technical expertise Business is tracking strongly to Prospectus dated 9 November 2018 (‘Prospectus’) forecasts with 63% of 1H 2019 forecast system revenue now under confirmed purchase order, versus ~50% at Prospectus date SAN LUIS OBISPO, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — Leading semiconductor equipment company, Revasum, Inc.’s

HedgeServ Significantly Enhances Treasury Management Service Offering with Expanded Hazeltree Relationship

Expanded Treasury and Portfolio Finance Capabilities Provide Clients with Powerful Counterparty Cost Control & Operational Risk Reduction NEW YORK, LONDON and HONG KONG, Dec. 04, 2018 (GLOBE NEWSWIRE) — HedgeServ, a global fund administrator recognized for providing innovative, technology-backed solutions to the alternative investment industry, and Hazeltree, the leading provider of integrated buy-side treasury management solutions, today announced an expansion of their partnership. Powered by Hazeltree’s market-leading platform, HedgeServ will deliver comprehensive treasury and portfolio finance technology and operational support, as part of HedgeServ’s enhanced middle-office treasury services to alternative fund managers. Building upon their existing successful partnership around wires

Driven Inc. to Present at the 11th Annual LD Micro Main Event

SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Driven Inc. (OTC: RBOS), a cannabis delivery service, announced today that they will be presenting at the 11th Annual LD Micro Main Event. The conference is being held on December 4-6, 2018 at the Luxe Sunset Blvd Hotel, Los Angeles. Mr. Chris Boudreau, CEO and Mr. Brian Hayek, President of Driven will be presenting an overview of the Company as well as discussing recent business highlights. For those not able to attend, the presentation will be webcast.  Management will also be available for one-on-one meetings.  Date: Wednesday, December 5, 2018Time: 12:00 p.m.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Aphria, Inc.

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) — Levi & Korsinsky announces it has commenced an investigation of Aphria, Inc. (“Aphria” or “the Company”) (NYSE: APHA) concerning possible violations of federal securities laws. To obtain additional information, go to: https://www.zlk.com/pslra-1/aphria-inc-loss-form or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.

ATCO Awarded Modular Supply Contract for LNG Canada Workforce Accommodation Project

CALGARY, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) — ATCO Ltd. (TSX: ACO.X, ACO.Y) ATCO announced today that, through its wholly owned subsidiary ATCO Structures LNG Limited Partnership, it has entered into a joint venture with a subsidiary of Bird Construction Inc. to design, engineer and construct a 4,500-person workforce accommodation centre, known as the Cedar Valley Lodge. The facility will be built to house workers involved in the construction of LNG Canada’s natural gas liquefaction and export facility. The Bird-ATCO Joint Venture will execute a modular supply contract for 4,500 accommodation rooms for the Cedar Valley Lodge Project through a

Civeo Announces Room Commitment from LNG Canada for the Sitka Lodge in Kitimat, B.C. and Termination of Bird-Civeo Joint Venture

HOUSTON and CALGARY, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) — Civeo Corporation (“Civeo” or the “Company”) (NYSE:CVEO), one of the largest global providers of workforce accommodations, logistics and facility management services to the natural resource industry, announced today that it has been awarded a room commitment from LNG Canada. The Company also announced it has elected to terminate the Bird-Civeo Joint Venture (“B-C JV”) and no longer participate in the design and construction of LNG Canada’s Cedar Valley Lodge. LNG Canada Room Commitment at Sitka Lodge Civeo is pleased to announce today that it has been awarded a room commitment

News Release HP Appoints Kim Rivera as President, Strategy and Business Management

PALO ALTO, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) announced today that Kim Rivera, Chief Legal Officer and General Counsel, has been named President, Strategy and Business Management, effective January 1. She succeeds Interim Chief Operating Officer Cathie Lesjak who previously announced she will retire in early 2019.   Rivera is a proven leader who has spent her career working with Fortune 500 companies across multiple industries managing an array of business, strategy, risk and legal disciplines. She joined HP in 2015, responsible for all aspects of legal, government relations, compliance and ethics. In her expanded role,

Gettin’ Basted Takes Home Grand Champion Title at the 7th Annual and Final Smithfield® King of the Smoker Barbecue Competition

KANSAS CITY, Mo., Dec. 03, 2018 (GLOBE NEWSWIRE) — Smithfield® is proud to congratulate the brand’s sponsored pitmaster Brad Leighninger of Gettin’ Basted for taking home the Grand Champion title at the 2018 Smithfield King of the Smoker barbecue competition. This past weekend, 24 of the country’s most elite barbecue teams were invited to show off their skills at the Miramonte Resort in Indian Wells, Calif. to see who would be named the ultimate King of the Smoker.  Since 2012, Big Poppa Smokers has been hosting what has become known as one of the most premier barbecue competitions in the

Phase 1 Expansion Cohort Oral Presentations for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, in Relapsed/Refractory Acute Myeloid Leukemia Presented at 60th ASH Annual Meeting

Flotetuzumab demonstrated 29.4% complete response rate in evaluable primary refractory AML patients Translational studies suggest potential strategy for biomarker-based patient selection ROCKVILLE, Md., Dec. 03, 2018 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced clinical data from an ongoing Phase 1 study of flotetuzumab, MacroGenics’ CD123 x CD3 bispecific DART molecule, in two oral and two poster presentations at the 60th Annual Meeting of the American Society of Hematology (ASH), taking place in San Diego, CA on December 1-4, 2018. The

Mesa Air Group Announces Fourth Quarter and Fiscal Year 2018 Results

PHOENIX, Dec. 03, 2018 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported fourth quarter and Fiscal Year 2018 financial and operating results. Highlights for Fourth Quarter and Fiscal Year 2018 (ending September 30, 2018) Mesa’s Q4 2018 results reflect net income of $19.4 million, or $0.65 per diluted share, compared to net income of $5.5 million, or $0.23 per diluted share for Q4 2017.  Mesa’s Q4 2018 income before taxes was $26.6 million, compared to $10.2 million for Q4 2017.  In addition, Mesa’s EBITDA1 for Q4 2018 was $59.3 million, compared to $38.5 million in Q4 2017 and EBITDAR1 was

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tenaris S.A. – TS

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Tenaris S.A. (“Tenaris” or the “Company”) (NYSE: TS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Tenaris and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here to join a class action] On November 27, 2018, news outlets reported that an Argentine judge had indicted Paolo Rocca, Tenaris’s chairman and majority shareholder, in connection with a wide-ranging bribery scandal involving the government of